These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9658989)

  • 1. [Levels of malonyl dialdehyde and vitamin A in blood serum after administration of therapeutic doses of nifedipine].
    Misiewicz A; Sieradzka I; Dziewit T; Radwan K; Dutkiewicz B; Szota M
    Wiad Lek; 1998; 51(3-4):151-5. PubMed ID: 9658989
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of short term administration of cordafen on lipid peroxidation, activity of certain antioxidant enzymes and levels of reduced glutathione in erythrocytes].
    Misiewicz A; Radwan K; Dziewit T; Kowalczyk-Kowalska M; Dutkiewicz B
    Wiad Lek; 1997; 50(7-9):175-9. PubMed ID: 9507683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of nifedipine on serum endothelin-1 levels in essential hypertension.
    Akpolat T; Başkol M; Adam B; Arik N; Bedir A
    Clin Nephrol; 1997 Feb; 47(2):130-1. PubMed ID: 9049464
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Copper, zinc and vitamin C concentrations in polymorphonuclear granulocytes after administration of therapeutic doses of nifedipine in patients with primary hypertension].
    Misiewicz A; Jeleń B; Sieradzka I; Dziewit T; Szota M
    Wiad Lek; 1998; 51(11-12):480-3. PubMed ID: 10222839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with nifedipine retard: increasing doses as a therapeutic method].
    Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R
    Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertensive urgencies: how to give a low dose of short-acting nifedipine.
    Bloomfield RL; Carter J
    Geriatrics; 1996 Sep; 51(9):10. PubMed ID: 8814107
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
    Nakayama J; Koga T; Furue M
    Eur J Dermatol; 1998 Dec; 8(8):563-8. PubMed ID: 9889429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
    Kirby BJ; Kitchin NR
    Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients.
    Fukuda M; Masuda T; Ogura MN; Moriya T; Tanaka K; Yamamoto K; Ishii A; Yonezawa R; Noda C; Izumi T
    Hypertens Res; 2009 May; 32(5):392-8. PubMed ID: 19373239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
    Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New nifedipine preparation makes single daily dose possible].
    Fortschr Med; 1997 Nov; 115(33):following 54. PubMed ID: 9480274
    [No Abstract]   [Full Text] [Related]  

  • 19. Dangers, myths, controversy. Sublingual nifedipine for hypertensive crisis.
    Kaufman SE; Schneider EF
    JAAPA; 2000 Mar; 13(3):67-8, 71-4, 80. PubMed ID: 11503405
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker.
    Kamezaki F; Tasaki H; Yamashita K; Shibata K; Hirakawa N; Tsutsui M; Kouzuma R; Nagatomo T; Adachi T; Otsuji Y
    Hypertens Res; 2007 Aug; 30(8):699-706. PubMed ID: 17917317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.